...
首页> 外文期刊>Cost Effectiveness Resource Allocation >Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms
【24h】

Decision uncertainty and value of further research: a case-study in fenestrated endovascular aneurysm repair for complex abdominal aortic aneurysms

机译:进一步研究的决策不确定性和价值:复杂腹主动脉瘤的肝细胞内血管内动脉瘤修复的案例研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Fenestrated endovascular aneurysm repair (fEVAR) is a new approach for complex abdominal aortic aneurysms, limited to a few specialist centers, with limited evidence base. We developed a cost-effectiveness decision model of fEVAR compared to open surgical repair (OSR) to investigate the likely direction of costs and benefits and inform further research projects on this technology. A systematic review with meta-analysis and a four-state Markov model were used to estimate the cost-effectiveness of fEVAR versus OSR. We used a recent coverage with evidence development framework to characterize the main sources of uncertainty and inform decisions about the type of further research that would be most worthwhile and feasible. Seven observational comparative studies were identified, of which four presented odds ratios adjusted for confounders. The odds ratios for operative mortality varied widely between studies. Assuming a central estimate of the odds ratio of 0.54 (95% CI 0.05-6.24), the decision model estimated that the incremental cost per quality adjusted life year (QALY) was £74,580/QALY with a probability of 9 and 16% of being cost-effective at standard cost-effectiveness thresholds of £20,000/QALY and £30,000/QALY, respectively. The Expected Value of Perfect Information over 10?years at a threshold of £20,000/QALY was £11.2 million. Operative mortality contributed to most of the uncertainty in the decision model. In the case of "maturing technologies", decision modelling indicates the likely direction of costs and benefits and guides the development of further research projects. In our analysis of fEVAR versus OSR, decision uncertainty, particularly around operative mortality, might be effectively resolved by a short-term RCT, or possibly a well-conducted comparative observational study. Decision makers may consider that a conditional coverage decision is warranted with assessments required to make this type of recommendation depending on local priorities and circumstances.
机译:蕨类血管内动脉瘤修复(FEVAR)是复杂腹主动脉瘤的新方法,限于一些专业中心,证据基础有限。我们开发了一种成本效益的FEVAR决策模型,与公开外科修复(OSR)进行了调查了可能的成本方向和效益,并告知了这项技术的进一步研究项目。使用META分析和四州马尔可夫模型的系统审查用于估算FEVAR与OSR的成本效益。我们使用最近的覆盖范围与证据开发框架,以表征主要不确定性的主要来源,并告知决定是关于最有价值和可行的进一步研究的类型。鉴定了七项观察性比较研究,其中4种呈现了对混凝剂的含量比率。在研究之间的手术死亡率的差距比在研究之间变化。假设中央估计值为0.54(95%CI 0.05-6.24),决策模型估计,每个质量调整的生命年份(QALY)的增量成本为74,580英镑/ QALY,概率为9%和16%经济效益,标准成本效益阈值分别为20,000英镑/ QALY和30,000英镑/ QALY。完美信息的预期价值超过10岁以下的£20,000 / QALY的门槛为1120万英镑。手术死亡率导致决策模型中的大多数不确定性。在“成熟技术”的情况下,决策建模表明了成本和益处的可能方向,并指导进一步研究项目的发展。在我们对FEVAR与OSR的分析中,可以通过短期RCT有效地解决决策不确定性,特别是在术语中,可能会有效地解决,或者可能是一个良好的比较观察研究。决策者可能会考虑有条件的覆盖作出决定,根据当地优先事项和情况进行这类建议所需的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号